Laboratorios Monserrat y Eclair

What Laboratorios Monserrat y Eclair does

Laboratorios Monserrat y Eclair S.A. is an Argentine pharmaceutical laboratory founded in 1935 by Spanish pharmacist Francisco Méndez Vázquez and headquartered in the Constitución neighborhood of Ciudad Autónoma de Buenos Aires. After the founder's death and a brief closure, the company was acquired in March 1987 by a domestic economic group with prior pharmaceutical-industry ties since 1957 and reopened on April 11, 1988, launching FEBRIGRIP and PALATROBIL. Today the company manufactures and distributes an 87+ SKU portfolio across six therapeutic lines — analgesics/anti-inflammatories/antipyretics, antiseptic/respiratory, skin care, decongestants/antiallergics, gastrointestinal/natural products, and psychotropics/erectile dysfunction — under brands including ALGICLER, IBUCLER, REFENAX, DERMACLER, MICOCLIN, PALATROBIL, NOVAZOLAM, and VITARFIL.

Production is concentrated across three co-located plants within a 200-meter radius in Buenos Aires, operating under GMP standards with capacity of 10 million liquid or semi-solid units per single shift. All products are regulated by ANMAT and the company holds controlled-substance licensure for psychotropics (alprazolam, clonazepam). The portfolio also extends into cosmeceuticals (DERMACLER microsite, ACTIUM, ÁUREA intimate line, FRIPI ON repellents) and natural products (PALATROBIL herbal tea).

The business model is direct-to-pharmacy distribution: a field sales force personally and regularly visits approximately 90% of Argentine pharmacies, supported by the integrated tri-plant logistics structure. Since 2011, this direct-distribution model has been extended into Paraguay and Bolivia. The company is privately held, a member of CILFA since 1988 with a Board seat, and has 140 employees spanning technicians, administrative staff, operators, and the sales force. Alberto Pomerañetz serves as Director and General Manager. Revenue, funding history, and audited financials are not publicly disclosed.

Name

Laboratorios Monserrat y Eclair

Legal name

Laboratorios Monserrat y Eclair S.A.

Website

https://monserratyeclair.com.ar

Company type

Private

Founded year

1935

Operating status

Operating

Headcount range

101–250 employees

Short description

Laboratorios Monserrat y Eclair is an Argentine GMP-certified pharmaceutical laboratory (founded 1935, reopened 1988) that manufactures 87+ generic and OTC products across six therapeutic lines and distributes them directly to ~90% of Argentine pharmacies, with operations extended to Paraguay and Bolivia.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Dermatology Specialty Pharmaceuticals (HLAIACAL), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Pharmaceutical manufacturing
• Generic medications
• Cosmeceutical products
• OTC pharmaceutical products
• Pharmaceutical laboratory

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and selling branded generic pharmaceutical products across six therapeutic lines: Analgesics/Anti-inflammatories/Antipyretics, Antiseptic/Respiratory, Skin Care, Decongestants/Antiallergics, Gastrointestinal/Natural Products, and Psychotropics/Erectile Dysfunction. Products are sold directly to pharmacies across Argentina, Paraguay, and Bolivia.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Laboratorios Monserrat y Eclair is an Argentine pharmaceutical laboratory that manufactures and distributes a portfolio of more than 87 branded generic pharmaceutical and cosmeceutical products across six therapeutic lines, including analgesics, anti-inflammatories, antipyretics, antiseptics, respiratory treatments, skin care, decongestants, antiallergics, gastrointestinal and natural products, and psychotropics/erectile dysfunction treatments. Products are manufactured under GMP standards in three integrated Buenos Aires plants and sold directly to retail pharmacies across Argentina, Paraguay, and Bolivia through the company's own field sales force.

Product overview

Laboratorios Monserrat y Eclair S.A. is an Argentine pharmaceutical laboratory founded in 1935 that manufactures and distributes a portfolio of OTC and prescription medications across seven main therapeutic lines: Analgesics/Anti-inflammatories/Antipyretics (ALGICLER, IBUCLER, DEBRIL, NOVACLER, PARACETAMOL), Antiseptic/Respiratory (AMOXICLER, FEBRIGRIP, PULMOCLER, BUCOTRICIN, IVERMECTINA), Skin Care/Dermatological (DERMACLER, CALCUSAN, MICOCLIN, FRIPI, POVICLER, DIABECLER), Decongestants/Antiallergics (REFENAX, CIPROCLER), Gastrointestinal/Natural Products (PALATROBIL, KRITEL, AJOMAST, BECEBUEN, OPOCARBÓN), Psychotropics/Erectile Dysfunction (NOVAZOLAM, RIBOCLER, VITARFIL), and Intimate Care (ÁUREA line). The company also produces cosmeceutical products (ACTIUM facial care, FRIPI insect repellents) and maintains a presence in Paraguay and Bolivia. All products are regulated by ANMAT and manufactured under GMP standards.

Differentiator

Problem solved

Functional benefit

Brands

• DERMACLER: Dermatological care product line including creams, emulsions and protective solar products for skin care. The company operates a dedicated micrositio at dermacler.com.ar for this brand.

Products and services

• Analgesics, Anti-inflammatories and Antipyretics product line

Quantifiable outcome

• 10,000,000 units produced per single shift
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• CILFA (Cámara Industrial de Laboratorios Farmacéuticos Argentinos)notableOthers · 1 January 1988Laboratorios Monserrat y Eclair has been associated with CILFA since 1988, the year of the company's reopening. The company also holds a seat on CILFA's Board of Directors (Comisión Directiva), representing its commitment to the Argentine pharmaceutical industry and national economic group.

Scale indicators5 records

Recent moves10 records

Expansion highlights4 records

Direct peers

• Laboratorios Baliarda: Argentine pharmaceutical laboratory manufacturing branded generics across multiple therapeutic areas including CNS, cardiovascular and respiratory categories. Direct comparable as a mid-sized Argentine GMP manufacturer with national pharmacy distribution and similar product breadth.
• Laboratorios Bagó: One of the largest Argentine pharmaceutical laboratories, manufacturing branded generics and specialty pharma distributed nationally to pharmacies and institutions. Highly comparable in business model (domestic GMP manufacturing, broad pharmacy distribution) and product mix (analgesics, anti-infectives, dermatology, psychotropics), though at significantly larger scale.
• Gador: Argentine pharmaceutical laboratory producing branded generics and specialty products across multiple therapeutic categories, distributed nationally through pharmacies and institutions. Directly comparable in product breadth, GMP manufacturing model, and Argentine pharmacy-channel focus.
• Laboratorios Casasco: Argentine pharmaceutical laboratory focused on branded generics across cardiovascular, metabolic, CNS and dermatology categories. Comparable mid-sized Argentine generics manufacturer with similar pharmacy-channel distribution and GMP-certified domestic production.
• Laboratorios Andrómaco: Argentine pharmaceutical laboratory with strong dermatology, gynecological and OTC product lines distributed to pharmacies. Particularly relevant as a peer given Monserrat y Eclair's DERMACLER dermatology line and ÁUREA feminine care range, overlapping in cosmeceutical-adjacent pharmacy SKUs.
• Roemmers: Major Argentine pharmaceutical laboratory with a broad branded-generic and specialty portfolio across multiple therapeutic areas, distributed through its own field force. Comparable to Laboratorios Monserrat y Eclair in core FDF manufacturing, therapeutic diversification, and pharmacy-channel distribution in Argentina.
• Laboratorios Bernabó: Argentine pharmaceutical laboratory with branded-generic portfolio spanning multiple therapeutic lines distributed to pharmacies. Comparable as a long-established Argentine generics manufacturer with similar GMP-certified manufacturing and OTC/prescription pharmacy channel model.
• Laboratorios Montpellier: Argentine pharmaceutical laboratory with a diversified portfolio of branded generics across dermatology, gastroenterology and respiratory categories, sold through pharmacy channels. Similar mid-tier Argentine generics manufacturer with overlapping therapeutic lines including skin care and gastrointestinal products.

Broad incumbents

• Genomma Lab Internacional: Large Latin American OTC and personal-care pharmaceutical company with a broad portfolio across dermatology, gastrointestinal, respiratory and intimate care categories. Relevant as a regional incumbent operating in Argentina with overlapping OTC and cosmeceutical categories, but at materially larger scale and with multinational marketing reach.
• Bayer (Consumer Health, Argentina): Multinational pharmaceutical company with a Consumer Health division operating in Argentina across analgesics, dermatology, gastrointestinal and allergy categories. Comparable at the product-category level (e.g., aspirin/analgesics, topical dermatology) but competes from a global brand and R&D base rather than a domestic generics focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC6z1Rqp94u2VyV6b1KZuTEA
• Facebookfacebook.com/monserratyeclair
• LinkedInlinkedin.com/company/laboratorios-monserrat-y-eclair

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Monserrat y Eclair